Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Technology services tags : Fda save search
Simulations Plus and the University of Bath Awarded New FDA Grant - March 5, 2024
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 0.07%
H: 3.92%
C: 3.18%
fda grant plus
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: -1.15%
H: 1.11%
C: -0.64%
fda company collaboration grant plus
Simulations Plus Receives New FDA Grant Award
Published: 2023-09-21 (Crawled : 13:30) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: -0.56%
H: 0.0%
C: -1.16%
fda award grant plus
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
Published: 2023-06-29 (Crawled : 22:00) - globenewswire.com
RNLX | $0.811 -2.29% -2.34% 210K
|
Technology Services
|
| O: 39.61%
H: 9.69%
C: 1.04%
fda disease kidney authorization risk grants diabetes
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
Published: 2023-04-18 (Crawled : 14:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 0.58%
H: 0.85%
C: -2.69%
fda software plus
Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies
Published: 2023-04-10 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 1.22%
H: 0.0%
C: -0.4%
ORCL | News | $116.0 -2.25% 0.0% 6.6M
|
Technology Services
|
| O: -1.29%
H: 0.45%
C: -0.97%
fda drug tools
Simulations Plus and the University of Bath Awarded New FDA Grant
Published: 2022-11-15 (Crawled : 14:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 1.58%
H: 3.61%
C: 1.5%
fda grant plus
Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
Published: 2022-11-02 (Crawled : 13:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 0.1%
H: 6.12%
C: 1.26%
fda contract plus
FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat Post-Cardiac Surgery Pain
Published: 2022-09-22 (Crawled : 15:00) - prnewswire.com
ANSS | $324.43 -0.37% -0.37% 210K
|
Technology Services
|
| O: -0.88%
H: 0.45%
C: -0.57%
fda device
Improvita Successfully Completes Human Factors Validation Program Supporting Beyond Air's LungFit® PH FDA Approval
Published: 2022-08-16 (Crawled : 13:00) - biospace.com/
NNBR | $3.9 0.52% 0.51% 170K
|
Producer Manufacturing
|
| O: 0.43%
H: 1.27%
C: -0.42%
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: -1.05%
H: 1.55%
C: -7.36%
lungfit fda program approval
FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat C-Section Pain
Published: 2022-07-28 (Crawled : 14:20) - biospace.com/
ANSS | $324.43 -0.37% -0.37% 210K
|
Technology Services
|
| O: -0.26%
H: 4.84%
C: 4.52%
fda device
FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain
Published: 2022-07-14 (Crawled : 15:00) - biospace.com/
ANSS | $324.43 -0.37% -0.37% 210K
|
Technology Services
|
| O: -0.76%
H: 1.13%
C: 0.74%
fda device diabetic
FDA Roundup: July 1, 2022
Published: 2022-07-01 (Crawled : 16:00) - fda.gov
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: -0.3%
H: 11.69%
C: 11.24%
fda
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: -0.16%
H: 1.44%
C: -7.67%
lungfit fda respiratory approval
Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
SDGR | News | $24.37 -2.68% -2.75% 670K
|
Technology Services
|
| O: -2.14%
H: 1.89%
C: -4.09%
sgr-1505 fda clearance drug application
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: -1.22%
H: 0.0%
C: -6.25%
fda software license
Simulations Plus Successfully Delivers FDA-Funded Project
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 0.56%
H: 4.59%
C: 4.21%
fda
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
Published: 2021-10-26 (Crawled : 13:15) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: 4.59%
H: 0.0%
C: 0.0%
fda contract injection
U.S. FDA Renews Licenses of DILIsym Software
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
SLP | $44.49 -0.47% -0.47% 98K
|
Technology Services
|
| O: -0.75%
H: 1.93%
C: 0.6%
fda software license
iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography
Published: 2021-03-15 (Crawled : 23:00) - globenewswire.com
ICAD | $1.57 0.64% 0.64% 140K
|
Technology Services
|
| O: 9.39%
H: 0.2%
C: -8.05%
fda clearance fda clearance
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.